HC Wainwright & Co. Maintains Buy on Prothena Corp, Maintains $90 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Andrew Fein maintains a Buy rating on Prothena Corp (NASDAQ:PRTA) with a maintained price target of $90.
March 13, 2024 | 1:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Prothena Corp maintains a Buy rating and a $90 price target from HC Wainwright & Co., indicating a positive outlook.
The maintenance of a Buy rating and a high price target of $90 by a reputable analyst firm like HC Wainwright & Co. suggests a strong confidence in Prothena Corp's future performance. This endorsement is likely to instill investor confidence, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100